KYMR
Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc. (KYMR) has 19 SEC Form 4 filings (190 transaction rows) in the rolling window, disclosed by 7 distinct insiders. Most recent filing: Jul 8, 2026.
The most active filer is Director Booth Bruce with 11 filings. Insiders have net sold $396.1M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Nello Mainolfi
- Employees:208
- HQ:Watertown, MA, US
- IPO:2020-08-21
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$417.8M
reported sales (SEC code S)
Unique Insiders
7
in the rolling window
Market Cap
$9.4B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Executive Officer | Sale | 50,000 | $6.0M | Jul 8 | SEC ↗ | |
Jacobs Bruce N.First filing | Chief Financial Officer | Sale | 77,109 | $8.9M | Jul 2 | SEC ↗ |
| Chief Business Officer | Sale | 3,389 | $387K | Jul 2 | SEC ↗ | |
Mainolfi NelloFirst filing | Chief Executive Officer | Sale | 80,000 | $9.2M | Jul 2 | SEC ↗ |
| Director | Sale | 153,300 | $16.6M | Jul 2 | SEC ↗ | |
| Director | Sale | 467,878 | $51.6M | Jun 30 | SEC ↗ | |
BVF PARTNERS L P/ILFirst filing | See Remarks and Footnotes | Sale | 1,630,658 | $173.7M | Jun 26 | SEC ↗ |
| Director | Sale | 548,321 | $65.1M | Jun 26 | SEC ↗ | |
| Director | Sale | 1,408 | $141K | Jun 26 | SEC ↗ | |
| Director | Sale | 134,720 | $13.5M | Jun 26 | SEC ↗ | |
| Chief Business Officer | Sale | 5,000 | $570K | Jun 25 | SEC ↗ | |
| Director | Sale | 278,128 | $27.6M | Jun 23 | SEC ↗ | |
Booth BruceFirst in 6 months | Director | Sale | 116,812 | $10.6M | Jun 23 | SEC ↗ |
Booth BruceFirst in 6 months | Director | Sale | 115,056 | $10.5M | Jun 23 | SEC ↗ |
Goodman NoahFirst filing | Chief Business Officer | Sale | 2,500 | $248K | Jun 22 | SEC ↗ |
Chadwick Jeremy GFirst filing | Chief Operating Officer | Sale | 12,905 | $1.0M | May 27 | SEC ↗ |
Chadwick Jeremy GFirst filing | Chief Operating Officer | Sale | 4,279 | $349K | May 27 | SEC ↗ |
Ridloff ElenaFirst filing | Director | Sale | 3,000 | $261K | May 11 | SEC ↗ |
| Insider | Sale | 229,809 | $21.1M | Dec 12 | SEC ↗ | |
| Insider | Sale | 6,101 | $557K | Dec 12 | SEC ↗ | |
| Insider | Sale | 678 | $62K | Dec 12 | SEC ↗ |
Related companies
Kymera Therapeutics, Inc. is in the Healthcare sector.